MicroVision Announces Addition of Dr. Mark B. Spitzer to its Board of Directors
June 04 2020 - 8:30AM
MicroVision, Inc. (Nasdaq: MVIS), a leader in innovative
ultra-miniature laser display and sensing technology, today
announced it has elected Dr. Mark B. Spitzer to its board of
directors.
Dr. Spitzer is an experienced technology innovator with
expertise in eyewear- and head-mounted systems, micro-displays,
imaging optics for AR and VR, and photovoltaics. He has a strong
record of inventive entrepreneurship with 70 issued US patents,
over 86 publications and leadership positions with ground-breaking
technology companies. His experience in technology development and
management includes serving as Principal Scientist at Kopin
Corporation in the early 1990s where he led DARPA-funded
development of micro-displays for military head-mounted systems. In
1996 Dr. Spitzer founded the MicroOptical Corporation (eventually
renamed Myvu), where as CEO he launched several industrial and
consumer eyewear-based AR products. In 2012 Dr. Spitzer
joined Google X as Director of Operations for Glass, and later
moved to the VR team at Google where he helped build expertise in
VR hardware design. He retired in 2017.
Dr. Spitzer is a Fellow of the American Physical Society and a
Senior Member of the IEEE. In 2014 he received the Special
Recognition Award from the Society for Information Display in 2014
for contributions to the development of active-matrix
liquid-crystal micro-displays, micro-display viewing optics, and
wearable computer technology. Dr. Spitzer earned his B.A. with
distinction in physics at Boston University and his Ph.D. in
physics at Brown University.
“Mark has an extensive background in leading technology
innovation and development from startups to large Fortune 100
companies and we are fortunate to have him join our board,” said
Brian Turner, Chairman and Lead Independent Director at
MicroVision. “Mark brings a keen understanding of technology,
business strategy, operations and management and is a valuable
addition to the MicroVision board of directors.”
“I believe this is an exciting time to join the MicroVision
board and I look forward to working with Brian, my fellow directors
and management as the Company continues to explore strategic
options with Craig-Hallum Capital Group, LLC, its financial
advisor, for its impressive technology,” said Dr. Spitzer. “I
am thrilled to have this opportunity to help the Company navigate a
path to success.”
About MicroVision
MicroVision is the creator of PicoP® scanning technology, an
ultra-miniature sensing and projection solution based on the laser
beam scanning methodology pioneered by the Company. MicroVision’s
platform approach for this sensing and display solution means that
its technology can be adapted to a wide array of applications and
form factors. We combine our hardware, software, and algorithms to
unlock value for our customers by providing them a differentiated
advanced solution for a rapidly evolving, always-on world.
MicroVision has a substantial portfolio of patents relating to
laser beam scanning projection and sensing. MicroVision’s
industry leading technology is a result of its extensive research
and development. The Company is based in Redmond, Washington.
MicroVision and PicoP are trademarks of MicroVision, Inc. in the
United States and other countries. All other trademarks are the
properties of their respective owners.
Forward-Looking Statements
Certain statements contained in this release, including those
relating to potential of the Company, potential strategic options,
commercialization of the Company’s technology, the Company’s future
products and product applications and those including words like
“believe” are forward-looking statements that involve a number of
risks and uncertainties that could cause actual results to differ
materially from those in the forward-looking statements. Factors
that could cause actual results to differ materially from those
projected in our forward-looking statements include the risk that
the Company may not succeed in finding strategic solutions,
including a potential sale of the Company, with acceptable timing,
benefits or costs, the Company may be unable to evidence compliance
with Nasdaq criteria within the period of time that was granted by
the Nasdaq panel, our ability to operate with limited cash or to
raise additional capital when needed; market acceptance of our
technologies and products; and for products incorporating our
technologies; the failure of our commercial partners to perform as
expected under our agreements, including from the impact of the
COVID-19 (coronavirus); our ability to identify parties interested
in paying any amounts or amounts we deem desirable for the purchase
or license of intellectual property assets; our or our customers’
failure to perform under open purchase orders, our financial and
technical resources relative to those of our competitors; our
ability to keep up with rapid technological change; government
regulation of our technologies; our ability to enforce our
intellectual property rights and protect our proprietary
technologies; the ability to obtain additional contract awards and
develop partnership opportunities; the timing of commercial product
launches and delays in product development; the ability to achieve
key technical milestones in key products; dependence on third
parties to develop, manufacture, sell and market our products;
potential product liability claims; our ability to maintain our
listing on the Nasdaq Stock Market, and other risk factors
identified from time to time in the Company's SEC reports,
including the Company's Annual Report on Form 10-K filed with the
SEC. These factors are not intended to represent a complete list of
the general or specific factors that may affect us. It should
be recognized that other factors, including general economic
factors and business strategies, may be significant, now or in the
future, and the factors set forth in this release may affect us to
a greater extent than indicated. Except as expressly required by
federal securities laws, we undertake no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events, changes in circumstances
or any other reason.
Investor Relations Contact
David H. Allen Darrow Associates, Inc. 408.427.4463
dallen@darrowir.com
Microvision (NASDAQ:MVIS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Microvision (NASDAQ:MVIS)
Historical Stock Chart
From Sep 2023 to Sep 2024